AT366689B - Verfahren zur herstellung von neuen spirooxazolidindionen - Google Patents

Verfahren zur herstellung von neuen spirooxazolidindionen

Info

Publication number
AT366689B
AT366689B AT0560579A AT560579A AT366689B AT 366689 B AT366689 B AT 366689B AT 0560579 A AT0560579 A AT 0560579A AT 560579 A AT560579 A AT 560579A AT 366689 B AT366689 B AT 366689B
Authority
AT
Austria
Prior art keywords
spirooxazolide
indions
producing new
producing
new
Prior art date
Application number
AT0560579A
Other languages
English (en)
Other versions
ATA560579A (de
Inventor
Rodney Caughren Schnur
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ATA560579A publication Critical patent/ATA560579A/de
Application granted granted Critical
Publication of AT366689B publication Critical patent/AT366689B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
AT0560579A 1978-08-21 1979-08-20 Verfahren zur herstellung von neuen spirooxazolidindionen AT366689B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/935,199 US4200642A (en) 1978-08-21 1978-08-21 Spiro-oxazolidindiones

Publications (2)

Publication Number Publication Date
ATA560579A ATA560579A (de) 1981-09-15
AT366689B true AT366689B (de) 1982-04-26

Family

ID=25466700

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0560579A AT366689B (de) 1978-08-21 1979-08-20 Verfahren zur herstellung von neuen spirooxazolidindionen

Country Status (34)

Country Link
US (1) US4200642A (de)
JP (4) JPS6011914B2 (de)
AR (1) AR225614A1 (de)
AT (1) AT366689B (de)
AU (1) AU535170B2 (de)
BE (1) BE878311A (de)
CA (1) CA1121361A (de)
CH (1) CH639974A5 (de)
CS (1) CS208129B2 (de)
DD (1) DD146602A5 (de)
DE (2) DE2953954C2 (de)
DK (1) DK258479A (de)
EG (1) EG14639A (de)
ES (1) ES483511A1 (de)
FI (1) FI65255C (de)
FR (3) FR2442851A1 (de)
GB (2) GB2028318B (de)
GR (1) GR71913B (de)
HU (1) HU179746B (de)
IE (1) IE48932B1 (de)
IL (1) IL58076A (de)
IN (1) IN152416B (de)
IT (1) IT1123536B (de)
LU (1) LU81613A1 (de)
NL (1) NL7906318A (de)
NO (1) NO792699L (de)
NZ (1) NZ191350A (de)
PH (1) PH18091A (de)
PL (1) PL130686B1 (de)
PT (1) PT70086A (de)
SE (1) SE447116B (de)
SU (1) SU942597A3 (de)
YU (1) YU41488B (de)
ZA (1) ZA794379B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4329459A (en) * 1980-05-05 1982-05-11 The Upjohn Company Tetrahydrobenzopyran derivatives
GB2080803B (en) * 1980-07-28 1984-01-18 Pfizer Hypoglycemic 5-substituted oxazolidine-2,4-diones
US4367234A (en) * 1980-07-28 1983-01-04 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones
ES515751A0 (es) * 1981-10-13 1983-10-16 Pfizer "un procedimiento por analogia para la preparacion de derivados de espiro-oxindol-oxazolidindiona".
US4464385A (en) * 1982-04-15 1984-08-07 Alcon Laboratories, Inc. Treatment of diabetic complications with hydantoins
US4436745A (en) 1982-04-15 1984-03-13 Alcon Laboratories, Inc. Method of inhibiting aldose reductase activity
US4438272A (en) 1982-04-15 1984-03-20 Alcon Laboratories, Inc. Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones
US4540700A (en) * 1982-04-15 1985-09-10 Alcon Laboratories, Inc. Treatment of diabetic complications with certain spiro-imidazolidine-diones
ZA832679B (en) * 1982-05-07 1983-12-28 Ici Plc Indoline derivatives
US4430337A (en) * 1982-06-23 1984-02-07 Pfizer Inc. Alicyclic substituted oxazolidine-2,4-diones having hypoglycemic activity
US4556670A (en) * 1982-12-06 1985-12-03 Pfizer Inc. Spiro-3-hetero-azolones for treatment of diabetic complications
US4533667A (en) * 1983-05-25 1985-08-06 Pfizer Inc. Imidazolidinedione derivatives
US4464380A (en) * 1983-05-25 1984-08-07 Pfizer Inc. Imidazolidinedione derivatives
DK277484A (da) * 1983-06-23 1984-12-24 Hoffmann La Roche Thiazolidinderivater
JPS61200991A (ja) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk スピロ―３―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤
DE3522791C1 (en) * 1985-06-26 1987-01-02 Ferroplast Gmbh Positioning wall for lagging a cavity to be filled with a hardenable material in mining or tunnelling
HU206618B (en) * 1986-01-17 1992-12-28 Pfizer Process for producing hydroxyacetic acid derivatives for treating complications of diabetes and pharmaceutical compositions containing them
US5039672A (en) * 1990-04-05 1991-08-13 Pfizer Inc. Heterocyclic compounds as aldose reductase inhibitors
US5068332A (en) * 1990-10-12 1991-11-26 American Home Products Corporation Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones useful as aldose reductase inhibitors
US5102886A (en) * 1990-10-12 1992-04-07 American Home Products Corporation 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones and analogs thereof useful as aldose reductase inhibitors
FR2707981B1 (fr) * 1993-07-20 1995-09-01 Adir Nouveaux dérivés de benzospiroalcène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
JP2003502370A (ja) 1999-06-18 2003-01-21 メルク エンド カムパニー インコーポレーテッド アリールチアゾリジンジオン誘導体およびアリールオキサゾリジンジオン誘導体
DE60029446T2 (de) 1999-06-18 2007-02-08 Merck & Co., Inc. Arylthiazolidindione und aryloxazolidindion-derivate
ITPI20060083A1 (it) * 2006-07-11 2008-01-12 Univ Pisa Derivati 2,2-dimetilcromanici 4-spiro-eterocicilici azotati (a 5 e 6 termini) n-sostituiti quali cardio-protettori nei confronti dell'insulto ischemico
USD775790S1 (en) * 2015-11-18 2017-01-10 Ginger Damon Motorcycle jacket
RU2020123382A (ru) 2017-12-21 2022-01-21 Эссити Хайджин Энд Хелт Актиеболаг Впитывающее изделие и способ изготовления впитывающего изделия
BR112020008382A2 (pt) 2017-12-21 2020-11-03 Essity Hygiene And Health Aktiebolag artigo absorvente com vedações de canal e método para a fabricação do artigo absorvente

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1204232B (de) * 1959-07-16 1965-11-04 Ncr Co Verfahren zur Herstellung von Derivaten von 3-Alkyl-3'-methyl-spiro[benzoxazolin-2, 2'-(2'H-1'-benzopyran)]
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents

Also Published As

Publication number Publication date
AU535170B2 (en) 1984-03-08
DE2933441A1 (de) 1980-02-28
JPS5946517B2 (ja) 1984-11-13
PT70086A (en) 1979-09-01
EG14639A (en) 1985-03-31
GB2033904A (en) 1980-05-29
BE878311A (fr) 1980-02-20
LU81613A1 (fr) 1980-04-21
AU5009279A (en) 1980-02-28
YU41488B (en) 1987-08-31
ATA560579A (de) 1981-09-15
FI65255C (fi) 1984-04-10
FR2440949B1 (de) 1981-06-12
FR2440949A1 (fr) 1980-06-06
IN152416B (de) 1984-01-07
JPS55129279A (en) 1980-10-06
HU179746B (en) 1982-12-28
ES483511A1 (es) 1980-09-01
CA1121361A (en) 1982-04-06
FR2440950A1 (fr) 1980-06-06
SE447116B (sv) 1986-10-27
DE2953954C2 (de) 1987-12-03
DE2953954A1 (de) 1982-09-02
ZA794379B (en) 1980-08-27
GB2028318B (en) 1982-08-04
JPS55129280A (en) 1980-10-06
GB2033904B (en) 1982-08-04
YU199979A (en) 1983-06-30
FR2442851A1 (fr) 1980-06-27
SE7906949L (sv) 1980-02-22
NO792699L (no) 1980-02-22
GR71913B (de) 1983-08-16
FI65255B (fi) 1983-12-30
NZ191350A (en) 1984-04-27
IL58076A (en) 1982-07-30
IE48932B1 (en) 1985-06-26
GB2028318A (en) 1980-03-05
JPS55129288A (en) 1980-10-06
AR225614A1 (es) 1982-04-15
SU942597A3 (ru) 1982-07-07
DD146602A5 (de) 1981-02-18
PH18091A (en) 1985-03-20
JPS6011915B2 (ja) 1985-03-28
CH639974A5 (fr) 1983-12-15
PL130686B1 (en) 1984-08-31
US4200642A (en) 1980-04-29
JPS5943954B2 (ja) 1984-10-25
DE2933441C2 (de) 1987-04-23
CS208129B2 (en) 1981-08-31
FR2440950B1 (de) 1981-06-12
IE791592L (en) 1980-02-21
IT7925182A0 (it) 1979-08-20
IL58076A0 (en) 1979-12-30
IT1123536B (it) 1986-04-30
FI792567A (fi) 1980-02-22
FR2442851B1 (de) 1983-06-17
JPS5528996A (en) 1980-02-29
DK258479A (da) 1980-02-22
PL217881A1 (de) 1981-01-02
JPS6011914B2 (ja) 1985-03-28
NL7906318A (nl) 1980-02-25

Similar Documents

Publication Publication Date Title
AT366689B (de) Verfahren zur herstellung von neuen spirooxazolidindionen
ATA590680A (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
AT368509B (de) Verfahren zur herstellung von neuen 3-vinylcephalosporinen
AT376684B (de) Verfahren zur herstellung von neuen bor-silicium- verbindungen
AT373871B (de) Verfahren zur herstellung von neuen alpha -phenylpyrrolidin-2-methanol-derivaten
ATA363379A (de) Verfahren zur herstellung von neuen 4-amino-2piperidinochinazolinderivaten
AT364097B (de) Verfahren zur herstellung von neuen bicyclooctanderivaten
AT366365B (de) Verfahren zur herstellung von neuen 4-nitro-2trichlormethylphenyldisulfiden
AT369377B (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
AT367397B (de) Verfahren zur herstellung von neuen n-phenaethyl- glycinamiden
AT362872B (de) Verfahren zur herstellung von neuen demethylmaytansinoiden
AT371478B (de) Verfahren zur herstellung von neuen 7-alphamethoxycephalosporinderivaten
AT368516B (de) Verfahren zur herstellung von neuen nitrosoharnstoff-verbindungen
ATA291979A (de) Verfahren zur herstellung von neuen ver- bindungen
AT364347B (de) Verfahren zur herstellung von neuen 1beta-hydroxy-2beta-alkenyl-3-methylencyclopentan-4 beta-yl-cyclopropancarboxylaten
AT373896B (de) Verfahren zur herstellung von neuen ergopeptidalkaloidderivaten
AT362067B (de) Verfahren zur herstellung von neuen deoxyanthracyclinen
AT368517B (de) Verfahren zur herstellung von neuen nitrosoharnstoffverbindungen
AT364458B (de) Verfahren zur herstellung von neuen oleandomycinderivaten
AT371475B (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
AT366698B (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
ATA831278A (de) Verfahren zur herstellung von neuen 3-di-n- -propyl-acetoxy-benzodiazepin-2-onen
ATA330681A (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
ATA491481A (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
ATA491581A (de) Verfahren zur herstellung von neuen cephalosporinantibiotika

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee